The results showed that MKI67, TPX2, CDK1, CCNB2, UBE2C, CCNA2, CCNB1, BUB1B, CENPF, and RRM2 were overexpressed consistently in the Cancer Genome Atlas Prostate Adenocarcinoma samples. This evidence concerns the gene UBE2C and prostate adenocarcinoma.